FDA Inspection
Lawrence Colwyn Hurst, M.D.Lawrence Colwyn Hurst, M.D. – FDA Inspection, Jul 6, 2009
Record Details
This FDA Inspection record concerns Lawrence Colwyn Hurst, M.D., with an inspection on July 6, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Lawrence Colwyn Hurst, M.D.
- Inspection Date
- July 6, 2009
- Product Type
- Drugs
View Company Profile
ID · 25a5cd9e-d895-46e1-9eb7-eba76e226ea4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 597810
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
4- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
- 21 CFR 312.66Changes in research
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.